Olivier Elemento’s weblog

Olivier’s science weblog

G Protein-Coupled Receptors July 29, 2008

Filed under: drug discovery — oelemento @ 3:59 pm

Being about to join a medical school, I have a growing interest in G protein coupled receptors (GPCRs). The reason is that 30% of the 800 known GPCRs are drug targets, and some of them are the targets of multiple drugs (half of the drugs target a GPCR, according to an interesting article in the current issue of The Scientist). GPCRs appear to control many processes, eg appetite, smell, heartbeat, sleep, etc. Some are involved in development (e.g. GPR50-null mutant mice never begin puberty), while at least another one can mediate retroviral entry (eg CCR5, targeted by anti-HIV Maraviroc). GPCRs usually bind a ligand, but some of them simply block other GPCRs by dimerizing with them (eg GPR50 blocks MT1 this way).

Could computational/systems biology help understand how GPCRs work ? Maybe. I am curious to see what the GPCR co-expression network (eg across human tissues) is like and how that correlates with drug targeting, whether that can predict heterodimerization or drug side effects. Since there is a lot of data about transcriptional response to drug treatment (eg, with the Connectivity Map from the Broad), it seems to me that it would also be interesting to ask how the transcriptional program upon treatment with drugs targeting different GPCRs actually differ (and whether there is some overlap). Also I am curious to see where GPCRs are expressed in the brain. If anybody has any other ideas, or is interested in working on some of these problems, please shoot me an email.

 

Moving to Weill Medical College of Cornell University July 25, 2008

Filed under: Uncategorized — oelemento @ 5:22 pm

On September 1st, I will be starting my own group at the Weill Medical College of Cornell University in Manhattan. My lab will be located at the Institute for Computational Biomedicine (ICB).

I have many exciting projects in mind, some of them will build on FIRE, FIRE-pro, PAGE and FastCompare, others are completely new. The overall goal will be to understand and predict cellular activity and regulation based on sequence (DNA, RNA and protein). The ultimate goal will be to develop translational research towards understanding diseases such as cancer, neurodegenerative disorders (and I am particularly interested in investigating brain gene expression in order to study the latter) and malaria. Importantly, I will seek close collaborations with experimentalists, and in fact I already have started collaborating with some experimental groups there at Weill.

I also have funds to hire several postdoctoral scientists, so if you are interested in working with me, please send me an email at ole2001@med.cornell.edu

 

Drug testing using zebrafish July 16, 2008

Filed under: drug discovery — oelemento @ 3:44 pm

The Scientist has a short but quite interesting article on how some scientists are using zebrafish to test drugs. As the article says, the zebrafish is the only model system that has organ systems comparable to ours (it’s a vertebrate, it has a heart, blood, nervous system, etc), that also fits into 96-well plates … combine that with efficient techniques for creating transgenic animals (a company sells a library of 11,000 mutant lines), full transparency, and you get a system with an amazing potential for discovering potential drug candidates, predicting side-effects, understanding mechanisms of action, etc. Most likely, all that’s missing right now is a smart system for automated image analysis …